March, 2024

For 2023, the median transaction value in healthcare was $46 million. For 2023, strategic buyers accounted for 95% of transactions.

Select recent notable publicly announced M&A transactions:

–Bristol-Myers Squibb Company announced its acquisition of RayzeBio for $4.2 billion in December 2023.

–Concentra Biosciences announced its acquisition of Reneo Pharmaceuticals for $62 million in December 2023.

–Bristol-Myers Squibb Company announced its acquisition of Karuna Therapeutics for $14.0 billion in December 2023.

–Cosette Pharmaceuticals closed its acquisition of Worldwide Rights of Vyleesifor $171 million in December 2023.

–H.I.G. Capital announced its acquisition of Zimmer Biomet Spine for $375 million in December 2023.

    Download Report